Evolutionary algorithms are actively used for de novo drug design, which are based on those concepts derived from biological evolution, including reproduction, mutation (fragment-based mutation and atom-based mutation), crossover, and selection
De novo drug design is a computational approach that generates novel molecular structures from atomi...
Approximately 25years ago the first computer applications were conceived for the purpose of automate...
The challenging field of de novo enzyme design is beginning to produce exciting results. The applica...
© 2008 Nicolaou and Pattichis Drug discovery and development is a complex, lengthy process and failu...
Abstract — Genetic algorithms, can be used to solve NP-hard problems in various domains, including c...
Computational enzyme design has emerged as a promising tool for generating made-to-order biocatalyst...
Looking back to the history of drug discovery a widespread concern about search for better quality h...
The inception of advanced bioactive agents has driven the growth for sustained drug delivery and the...
Drug discovery and development is a complex, lengthy process, and failure of a candidate molecule ca...
A method for computational drug design using an evolutionary algorithm, comprises evaluating virtual...
Many phases of rational drug design involve finding solutions to large combinatorial problems for wh...
A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry de...
A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry de...
The recent lapse in productivity in the pharmaceutical industry has facilitated the emergence of exp...
A novel concept, \u201cdrug evolution\u201d, is proposed to develop chemical libraries that have a h...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
Approximately 25years ago the first computer applications were conceived for the purpose of automate...
The challenging field of de novo enzyme design is beginning to produce exciting results. The applica...
© 2008 Nicolaou and Pattichis Drug discovery and development is a complex, lengthy process and failu...
Abstract — Genetic algorithms, can be used to solve NP-hard problems in various domains, including c...
Computational enzyme design has emerged as a promising tool for generating made-to-order biocatalyst...
Looking back to the history of drug discovery a widespread concern about search for better quality h...
The inception of advanced bioactive agents has driven the growth for sustained drug delivery and the...
Drug discovery and development is a complex, lengthy process, and failure of a candidate molecule ca...
A method for computational drug design using an evolutionary algorithm, comprises evaluating virtual...
Many phases of rational drug design involve finding solutions to large combinatorial problems for wh...
A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry de...
A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry de...
The recent lapse in productivity in the pharmaceutical industry has facilitated the emergence of exp...
A novel concept, \u201cdrug evolution\u201d, is proposed to develop chemical libraries that have a h...
De novo drug design is a computational approach that generates novel molecular structures from atomi...
Approximately 25years ago the first computer applications were conceived for the purpose of automate...
The challenging field of de novo enzyme design is beginning to produce exciting results. The applica...
DOI
Add to ORKG